XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XRTX XORTX Therapeutics Inc.

休市中 05-17 16:00:00 EDT

2.50

+0.15

+6.38%

盘后2.50

+0.00+0.00%

17:39 EDT

最高2.54	最低2.31	成交量7,484
今开2.49	昨收2.35	日振幅9.78%
总市值724.61万	流通市值658.07万	总股本289.86万
成交额1.84万	换手率0.28%	流通股本263.24万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XRTX","market":"US","secType":"STK","nameCN":"XORTX Therapeutics Inc.","latestPrice":2.4999,"timestamp":1715976000000,"preClose":2.35,"halted":0,"volume":7484,"hourTrading":{"tag":"盘后","latestPrice":2.5,"preClose":2.4999,"latestTime":"17:39 EDT","volume":100,"amount":250,"timestamp":1715981968311},"delay":0,"floatShares":2632386,"shares":2898565,"eps":-1.088978,"marketStatus":"休市中","marketStatusCode":7,"change":0.1499,"latestTime":"05-17 16:00:00 EDT","open":2.49,"high":2.54,"low":2.3101,"amount":18439.323178399998,"amplitude":0.09783,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.088978,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"adjPreClose":2.35,"preHourTrading":{"tag":"盘前","latestPrice":2.35,"preClose":2.43,"latestTime":"08:27 EDT","volume":7,"amount":16.529999500000002,"timestamp":1715948835103},"postHourTrading":{"tag":"盘后","latestPrice":2.5,"preClose":2.4999,"latestTime":"17:39 EDT","volume":100,"amount":250,"timestamp":1715981968311},"volumeRatio":0.5335196346257365},"requestUrl":"/m/hq/s/XRTX/","defaultTab":"news","newsList":[{"id":"2434601958","title":"Xortx Therapeutics Inc.盘中异动 股价大跌5.10%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434601958","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434601958?lang=zh_cn&edition=full","pubTime":"2024-05-11 02:04","pubTimestamp":1715364259,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日02时04分，Xortx Therapeutics Inc.股票出现异动，股价大幅下挫5.10%。截至发稿，该股报2.54美元/股，成交量1.5032万股，换手率0.52%，振幅8.49%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240511020419861ec7e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240511020419861ec7e7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433722203","title":"Xortx Therapeutics Inc.盘中异动 快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433722203","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433722203?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:17","pubTimestamp":1715177868,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日22时17分，Xortx Therapeutics Inc.股票出现波动，股价急速上涨5.26%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082217487a58c4ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082217487a58c4ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433200600","title":"Xortx Therapeutics Inc.股价上涨18.11% 市值涨23.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433200600","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433200600?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:30","pubTimestamp":1715088622,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时30分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨18.11%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721302387e86194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721302387e86194&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431865539","title":"Xortx Therapeutics Inc.盘中异动 快速拉升6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431865539","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431865539?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397515,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分，Xortx Therapeutics Inc.股票出现异动，股价快速拉升6.48%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921315587bf9a6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921315587bf9a6b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422542679","title":"Xortx Therapeutics Inc.盘中异动 快速下跌6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422542679","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422542679?lang=zh_cn&edition=full","pubTime":"2024-03-25 23:11","pubTimestamp":1711379462,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日23时11分，Xortx Therapeutics Inc.股票出现波动，股价急速跳水6.29%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发和潜在商业化疗法，以治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病以及孤儿（罕见）疾病适应症中的尿酸代谢， 以及与呼吸道病毒感染相关的 AKI。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032523110287e7b84e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032523110287e7b84e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420044747","title":"Xortx Therapeutics Inc.盘中异动 股价大跌7.88%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420044747","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420044747?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:39","pubTimestamp":1710941995,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时39分，Xortx Therapeutics Inc.股票出现异动，股价急速下挫7.88%。截至发稿，该股报4.56美元/股，成交量5437股，换手率0.19%，振幅3.43%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发和潜在商业化疗法，以治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病以及孤儿（罕见）疾病适应症中的尿酸代谢， 以及与呼吸道病毒感染相关的 AKI。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202139557a4df946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202139557a4df946&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420278342","title":"Xortx Therapeutics Inc.盘中异动 大幅上涨10.10%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420278342","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420278342?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:30","pubTimestamp":1710855030,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时30分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨10.10%。截至发稿，该股报5.34美元/股，成交量3.2321万股，换手率1.12%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Fusion Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Actinium Pharmaceuticals, Inc. 涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为360.60%、133.27%、116.42%，振幅较大的相关个股有珐博进、Enveric Biosciences, Inc.、Seelos Therapeutics, Inc.，振幅分别为7.83%、6.36%、5.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921303187e7a0d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921303187e7a0d6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472239","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大跌6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472239","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420472239?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:34","pubTimestamp":1710768886,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时34分，Xortx Therapeutics Inc.股票出现异动，股价快速下跌6.38%。截至发稿，该股报4.84美元/股，成交量1.6062万股，换手率0.55%，振幅4.45%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发和潜在商业化疗法，以治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病以及孤儿（罕见）疾病适应症中的尿酸代谢， 以及与呼吸道病毒感染相关的 AKI。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182134467a4d6f40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182134467a4d6f40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419706769","title":"Xortx Therapeutics Inc.盘中异动 急速上涨6.65%报5.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419706769","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419706769?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:19","pubTimestamp":1710512396,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时19分，Xortx Therapeutics Inc.股票出现异动，股价大幅上涨6.65%。截至发稿，该股报5.77美元/股，成交量1.6046万股，换手率0.55%，振幅6.99%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发和潜在商业化疗法，以治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病以及孤儿（罕见）疾病适应症中的尿酸代谢， 以及与呼吸道病毒感染相关的 AKI。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315221957861deb08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315221957861deb08&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xortx.com","stockEarnings":[{"period":"1week","weight":-0.008},{"period":"1month","weight":-0.2114},{"period":"3month","weight":0.121},{"period":"6month","weight":-0.1667},{"period":"1year","weight":-0.6206},{"period":"ytd","weight":0.0822}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"XORTX Therapeutics Inc.于2012年8月24日根据加拿大艾伯塔省的法律注册成立，名称为ReVasCor Inc.在2018年1月10日，公司名称更改为“XORTX Therapeutics Inc.”。该公司是一家临床阶段的生物技术公司，专注于识别、开发和商业化治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病的疗法，这些肾脏适应症包括ADPKD、冠状病毒COVID-19感染引起的AKI和T2DN。","exchange":"NASDAQ","name":"XORTX Therapeutics Inc.","nameEN":"XORTX Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"XORTX Therapeutics Inc.,XRTX,XORTX Therapeutics Inc.股票,XORTX Therapeutics Inc.股票老虎,XORTX Therapeutics Inc.股票老虎国际,XORTX Therapeutics Inc.行情,XORTX Therapeutics Inc.股票行情,XORTX Therapeutics Inc.股价,XORTX Therapeutics Inc.股市,XORTX Therapeutics Inc.股票价格,XORTX Therapeutics Inc.股票交易,XORTX Therapeutics Inc.股票购买,XORTX Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}